These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18087149)

  • 1. Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.
    van Westrhenen R; Aten J; Hajji N; de Boer OJ; Kunne C; de Waart DR; Krediet RT
    Blood Purif; 2007; 25(5-6):466-72. PubMed ID: 18087149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
    Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
    Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
    Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis.
    Fabbrini P; Schilte MN; Zareie M; ter Wee PM; Keuning ED; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2009 Dec; 24(12):3669-76. PubMed ID: 19666665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
    van Westrhenen R; Aten J; Aberra M; Dragt CA; Deira G; Krediet RT
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S18-21. PubMed ID: 16048249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution.
    Günal AI; Duman S; Sen S; Unsal A; Terzioğlu E; Akçiçek F; Basci A
    J Nephrol; 2001; 14(3):184-9. PubMed ID: 11439742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.
    Duman S; Wieczorowska-Tobis K; Styszynski A; Kwiatkowska B; Breborowicz A; Oreopoulos DG
    Adv Perit Dial; 2004; 20():31-6. PubMed ID: 15384791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failure.
    de Graaff M; Vlijm A; Zweers MM; Coester AM; Vandemaele F; Struijk DG; Krediet RT
    Adv Perit Dial; 2010; 26():7-11. PubMed ID: 21348371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
    Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
    Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
    Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
    Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.
    van Westrhenen R; Zweers MM; Kunne C; de Waart DR; van der Wal AC; Krediet RT
    Perit Dial Int; 2008; 28(5):487-96. PubMed ID: 18708542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: Modification by calcium channel blockade in the salt replete rat.
    Saggi SJ; Andoh TF; Safirstein R; Bennett WM
    Nephrology (Carlton); 2004 Apr; 9(2):58-64. PubMed ID: 15056263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
    Hung KY; Huang JW; Chiang CK; Tsai TJ
    Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
    Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
    Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
    J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.